Browse All

Current Filters

CLEAR FILTER x

TITLE

Characteristics and Treatment Patterns of Patients With Myasthenia Gravis: A Retrospective, Real-world Analysis of a United States Claims Database

Author:Khan, Farid   McConnon, Aine   Sinha, Sikha   Srivastava, Riya   Heaney, Andrew   DeLasHeras, Virginia   

Session Name:P11: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Treatments  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P11.001  

Author Institution:Novartis Pharmaceuticals Corporation, East Hanover, NJ  Novartis Ireland Ltd., Dublin, Ireland  Novartis Healthcare Pvt Ltd., Hyderabad, India  Novartis Pharma AG, Basel, Switzerland  

Pregnancy and Infant Outcomes in Women With Relapsing Multiple Sclerosis Following Exposure to Ofatumumab: Latest Evidence From the PRIM Study

Author:Bove, Riley   Stoll, Sharon   Dobson, Ruth   Amato, Maria   Kharat, Vineetkumar   Abeyewickreme, Anil   Jehl, Valentine   Kramarikova, Ivana   Yamout, Bassem   Krysko, Kristen   Vukusic, Sandra   Hellwig, Kerstin   

Session Name:P11: Multiple Sclerosis: Sex and Gender Informed Neurology  

Topic:Multiple Sclerosis  

Program Number:P11.002  

Author Institution:UCSF Weill Institute for Neurosciences, San Francisco, Berkeley, CA  Advocare, Stoll Medical Group, Philadelphia, Philadelphia, PA  Wolfson Institute of Population Health, London, United Kingdom  University of Florence, Florence, Italy  Novartis Pharmaceuticals Corporation, NJ  Novartis Pharmaceuticals UK Ltd., London, United Kingdom  Novartis Pharma AG, Basel, Switzerland  Harley Street Medical Center, Abu Dhabi, United Arab Emirates  St. Michael's Hospital, Toronto, ON, Canada  Lyon University Hospital, Lyon, France  St. Josef Hospital/Ruhr University Bochum, Bochum, Germany